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A B S T R A C T
Protein:protein interactions are the basis of molecular communication and are usually of transient non-covalent
nature, while covalent interactions other than ubiquitination are rare. For cellular adaptations, the cellular
oxygen and peroxide sensor factor inhibiting HIF (FIH) confers oxygen and oxidant stress sensitivity to the
hypoxia inducible factor (HIF) by asparagine hydroxylation. We investigated whether FIH contributes to hypoxia
adaptation also through other mechanisms and identified a hypoxia sensitive, likely covalent, bond formation by
FIH with several client proteins, including the deubiquitinase ovarian tumor domain containing ubiquitin al-
dehyde binding protein 1 (OTUB1). Biochemical analyses were consistent with a co-translational amide bond
formation between FIH and OTUB1, occurring within mammalian and bacterial cells but not between separately
purified proteins. Bond formation is catalysed by FIH and highly dependent on oxygen availability in the cellular
microenvironment. Within cells, a heterotrimeric complex is formed, consisting of two FIH and one covalently
linked OTUB1. Complexation of OTUB1 by FIH regulates OTUB1 deubiquitinase activity. Our findings reveal an
alternative mechanism for hypoxia adaptation with remarkably high oxygen sensitivity, mediated through
covalent protein-protein interactions catalysed by an asparagine modifying dioxygenase.
1. Introduction
Cellular oxygen sensing is of vital importance for cells and tissues in
order to adapt to hypoxic conditions when cellular oxygen demand
exceeds its supply [1]. The best characterized cellular oxygen sensors
are the prolyl-4-hydroxylase domain (PHD) proteins 1–3 and factor
inhibiting HIF (FIH) [2]. PHDs hydroxylate two different prolines and
FIH hydroxylates one asparagine residue of HIFα subunits [2]. Besides
molecular oxygen, these enzymes require Fe2+ and ascorbate or other
reducing agents as co-factors and 2-oxoglutarate as co-substrate in
order to reduce molecular oxygen and oxidize the substrate protein
(hydroxylation) and 2-oxoglutarate (conversion to succinate) [3,4].
Proline-4-hydroxylation of HIFα leads to its proteasomal degradation
whereas asparagine hydroxylation inhibits its interaction with the
transcriptional co-activators p300 and CBP, attenuating HIF-dependent
gene transactivation [2]. While in higher organisms the only known
reaction of 2-oxoglutarate-dependent dioxygenases is hydroxylation
[5], in lower organisms they also catalyse ring expansion, rearrange-
ment, desaturation, halogenation and epoxidation [6].
Beside oxygen, FIH also senses peroxide [7]. Interestingly, FIH is
more sensitive to H2O2 than the PHDs [7]. Peroxide reduces FIH en-
zymatic activity, leading to decreased HIF-1α asparagine hydroxylation
and higher transcriptional activity [7]. This indicates that FIH func-
tionally integrates oxidant stress and hypoxia in cellular signaling.
In vivo, FIH is essential for the regulation of energy metabolism
[8,9]. Amongst others, FIH deletion leads to an increased metabolic
rate, increased glucose and lipid homeostasis and increased oxidative
metabolism [8,9]. The FIH-dependent regulation of energy metabolism
is at least partly independent of HIF [8]. Therefore, a key question re-
maining is whether FIH regulates additional substrates outside of the
HIF pathway that contribute to the observed phenotype. FIH has pre-
viously been shown to target proteins for hydroxylation other than
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HIFα, including ankyrin repeat domain (ARD)-containing proteins
[10–15]. However, whether FIH-dependent hydroxylation of these
proteins is functionally relevant for the regulation of energy metabo-
lism is unclear [11,16]. We recently demonstrated that FIH interacts
with the deubiquitinase (DUB) ovarian tumor domain containing ubi-
quitin aldehyde binding protein 1 (OTUB1) and hydroxylates it on as-
paragine 22 (N22), regulating cellular energy metabolism [17,18].
OTUB1 is a ubiquitously expressed DUB with one of the highest
expression levels of all DUBs [19,20]. OTUB1 cleaves K48-ubiquitin
chains through its canonical enzymatic activity, preventing protea-
somal degradation of substrate proteins [21,22]. In addition, OTUB1
inhibits E2 ubiquitin-conjugating enzymes independent of its enzymatic
activity, impeding ubiquitin chain formation [23–25]. OTUB1 enzy-
matic activity is regulated by complexation with E2 enzymes and free
ubiquitin [26,27]. A major characteristic of DUBs is their frequent oc-
currence in protein complexes, which controls DUB activity [28].
However, whether other proteins in addition to E2 enzymes and free
ubiquitin affect OTUB1 activity by protein complexation is unknown.
In this study, we further investigated the molecular interplay be-
tween FIH and OTUB1. We show evidence for an unexpected formation
of a previously unknown strong, likely covalent, interaction between
FIH and OTUB1. We demonstrate that this formation has functional
consequences for OTUB1 deubiquitinase activity and is highly oxygen
sensitive but relatively slow, indicating a role in chronic hypoxia
adaptation. Interestingly, this type of FIH-dependent bond formation is
likely not restricted to the substrate OTUB1.
2. Materials and methods
2.1. Cell culture and transient transfection
Human HEK293 (embryonic kidney), MCF7 (breast adenocarci-
noma) and Hep3B (hepatocellular carcinoma) cell lines were cultured
in DMEM containing 4.5 g/l glucose, sodium pyruvate and L-glutamine
(Sigma-Aldrich, St Louis, MO, USA), supplemented with 10% heat-in-
activated fetal bovine serum (Gibco by Life Technologies, Carlsbad, Ca,
USA) and 100 U/ml penicillin and 100 μg/ml streptomycin (Sigma-
Aldrich). Transient transfection of siRNAs and plasmids was performed
using lipofectamine 2000 reagent according to the manufacturer's in-
structions (Invitrogen, Carlsbad, CA, USA) or polyethylenimine (PEI;
Polysciences Inc., Warrington, PA) as described previously [29].
2.2. Cell treatments
Cycloheximide (CHX; Sigma-Aldrich) was dissolved in ethanol;
desferrioxamine (DFX; Sigma-Aldrich), (+)-sodium L-ascorbate (Sigma-
Aldrich), 2-oxoglutarate (Sigma-Aldrich), diethyl 2-oxoglutarate (DE-
2OG; Sigma-Aldrich) and iron (II) sulfate (Sigma-Aldrich) in H2O; and
dimethyloxalylglycine (DMOG; Frontier Scientific, Logan, UT, USA) and
FG-4592 (Roxadustat; Selleckchem, Houston, TX, USA) in di-
methylsulfoxide (DMSO, Sigma-Aldrich). Hypoxic incubations were
performed using the InvivO2 400 humidified cell culture workstation
(Baker Ruskinn, Bridgend, South Wales, UK) operated at 0.2% O2 and
5% CO2 as described previously [29] or in humidified oxygen-regulated
cell culture incubators (Binder GmbH, Tuttlingen, Germany) operated
at 1%–8% O2 and 5% CO2. If not otherwise indicated, “normoxia” refers
to the standard oxygen concentration in the gas phase within a cell
culture incubator at 500m altitude (18.5% O2) and “hypoxia” to 0.2%
O2 [30].
2.3. Plasmids and siRNAs
The plasmid encoding human wildtype FIH-V5 was kindly provided
by Dr. Eric Metzen (University of Duisburg-Essen, Essen, Germany). The
plasmids encoding FIH H199A-V5 and MBP-FIH have previously been
described [31]. The plasmid coding for human wildtype FLAG-OTUB1
(containing two consecutive FLAG tags) [32] was a kind gift of Dr. Mu-
Shui Dai (Oregon Health & Science University, Portland, OR, USA). The
transfer vector pET3a and the polycistronic expression vector pST39
[33] were kind gifts from Prof. Song Tan (Pennsylvania State Uni-
versity, PA, USA).
Nontargeting siRNA (siNT: 5′-gcuccggagaacuaccagaguauua-3′) as
well as siRNA targeting human FIH (siFIH: sequence F1, 5′-guugcgca-
guuauagcuuctt-3′) and the 3′UTR of human OTUB1 (siOTUB1: siRNA-4,
5′-gugguuguaaaugguccuatt-3′) were purchased from Microsynth
(Balgrach, Switzerland) according to previously reported sequences
[10,34].
2.4. Generation of OTUB1 mutants by site-directed mutagenesis
The human FLAG-OTUB1 N22A mutant was previously described
[18]. The human FLAG-OTUB1 S16A, S18A, S16A/S18A, C23A, C23S,
C91A, C91S point mutants were generated using the Quikchange II XL
Site-Directed Mutagenesis kit (Agilent Technologies, Santa Clara, CA,
USA) according to the manufacturer's instructions and using the
plasmid encoding wildtype FLAG-OTUB1 as template. The mutations of
the target sites were confirmed by sequencing.
2.5. Immunoblot analysis
Cells were lysed in 150mM NaCl, 25mM Tris-HCl (pH 8.0), 1 mM
EDTA, 1% NP-40, freshly supplemented with protease inhibitor cocktail
(Sigma-Aldrich), 1 mM PMSF and 1mM Na3VO4 and 100mM iodoa-
cetamide where indicated. Protein concentrations of lysates were de-
termined using the BCA assay (Thermo Fisher Scientific, Waltham, MA,
USA). Equal amounts of proteins were mixed with 5x loading dye
(250mM Tris-HCl pH 6.8, 30% glycerol, 858mM β-mercaptoethanol,
10% SDS, 0.05% bromophenolblue), separated by SDS-PAGE, electro-
transferred to nitrocellulose membranes and detected using anti-FIH
antibody (Novus Biologicals, Littleton CO, USA; NBP1-30333), anti-V5
antibody (Invitrogen; R960-025), anti-OTUB1 antibody (Cell Signaling
Technology, Danvers, MA, USA; 3783), anti-FLAG antibody (Sigma-
Aldrich; F3165), anti-ubiquitin antibody (clone P4D1; Cell Signaling
Technology; 3936), anti–HIF–1α antibody (BD Biosciences, San Jose,
CA, USA; 610959), anti–HIF–2α antibody (Bethyl Laboratories,
Montgomery, TX, USA; A700-003), anti-GFP antibody (Roche
Diagnostics, Rotkreuz, Switzerland; 11814460001), anti-β-actin anti-
body (Sigma-Aldrich; A5441), anti-α-tubulin antibody (Cell Signaling;
2144), anti-SMC1 antibody (Abcam, Cambridge, UK; 9262) and
horseradish peroxidase-coupled secondary antibodies (Thermo Fisher
Scientific; 31430, 31460). Bound antibodies were detected with
SuperSignal enhanced chemiluminescence substrate (Thermo Fisher
Scientific) and chemiluminescence was recorded using a CCD camera
(LAS 4000 mini, Fujifilm, Tokyo, Japan). ImageQuant TL gel analysis
software (GE Healthcare, Version 8.1) was used for quantification as
previously described [35]. If not indicated otherwise, values were
normalized to the respective loading control and the sum of the in-
tensities of all samples of one signal of each experiment.
2.6. Denaturing urea and blue native electrophoresis
For urea electrophoresis, cells were harvested in 30mM Tris-HCl
(pH 8.5), 7M urea, 2M thiourea, 0.4% CHAPS, supplemented with
protease inhibitor cocktail (Sigma-Aldrich) as described [36]. The
protein concentration was determined by Bradford assay and equal
protein amounts were separated by 8% urea gel electrophoresis ac-
cording to the previous description [37,38]. For blue native electro-
phoresis, cells were harvested in 20mM Bis-Tris (pH 7.0), 500mM ε-
aminocaproic acid, 10% glycerol, supplemented with 1mM PMSF,
10 μg/ml aprotinin, 10 μg/ml leupeptin and 1mM Na3VO4, and lysed
by dounce homogenisation. The protein concentration was determined
by Bradford assay and equal protein amounts were separated by 15%
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blue native gel electrophoresis according to a previous description [39].
Following electrophoresis, proteins were transferred to nitrocellulose
membranes and detected using antibodies as described above.
2.7. Two-dimensional gel electrophoresis
Cell lysates were prepared for native protein analysis and separated
by blue native electrophoresis as described above. Single lanes were cut
and separated in the second dimension by SDS-PAGE in 100mM Tris-
HCl (pH 6.8), 12% glycerol, 343mM β-mercaptoethanol, 4% SDS,
0.02% bromophenolblue [40]. Following transfer to nitrocellulose
membranes, proteins were detected using antibodies as described
above.
2.8. Bacterial expression and purification of His- and MBP-tagged
recombinant proteins
The plasmids encoding human pENTR4-OTUB1 WT/N22A were
described previously [18] and utilized for generating pDEST17-OTUB1
WT/N22A (coding for His-OTUB1 WT/N22A) using the Gateway
system according to the manufacturer's description (Invitrogen). His-
OTUB1 WT/N22A was subcloned into the bacterial expression vector
pET3a using pDEST17-OTUB1 WT/N22A plasmids as templates. For
cloning of MBP-tagged human FIH into pET3a, FIH WT/H199A was
subcloned using pFIH WT/H199A-V5 as template, followed by sub-
cloning of an N-terminal MBP tag using human pMBP-FIH as template.
E.coli BL21(DE3)pLysS (Invitrogen) were transformed with the plasmids
and expression of the respective proteins was induced by addition of
0.2 mM isopropyl-ß-D-thiogalactoside (IPTG) for up to 6 h at 30°C. For
purification of His-tagged proteins, bacteria were resuspended in
20mM Tris-HCl (pH 8.0), 500mM NaCl, 5 mM imidazole, and for
purification of MBP-tagged proteins in 20mM Tris-HCl (pH 8.0),
150mM NaCl. Lysis buffers were supplemented with 1mM PMSF and
protease inhibitor cocktail (Sigma-Aldrich). Bacteria were lysed using a
cell disruptor (TS Series Bench Top, Constant Systems Ltd., Northants,
UK) in two cycles at 35 kPsi. Lysates were cleared by ultracentrifuga-
tion at 162,000 g, 4°C for 1 h and proteins were affinity purified with
NiSO4-charged sepharose (HiTrap Chelating HP, GE Healthcare, Little
Chalfot, UK) or dextrin sepharose (MBPTrap HP, GE Healthcare 28-918-
780) columns using the Duo Flow system (Bio-Rad, Hercules, CA, USA).
Protein concentrations were determined by Bradford assay. Dot blot,
colloidal Coomassie staining [41] and OTUB1 and FIH immunoblotting
were used to verify successful protein expression and purification.
2.9. Bacterial expression and purification of the stable FIH-OTUB1 complex
from a bicistronic expression vector
Cloning of a bicistronic expression vector was performed as de-
scribed [33]. Briefly, untagged human OTUB1 WT/N22A, FIH WT/
H199A, His-OTUB1 WT/N22A and MBP-FIH WT/H199A were cloned
into the transfer vector pET3a following PCR amplification. Untagged
OTUB1 WT/N22A or His-OTUB1 WT/N22A was subsequently sub-
cloned into cassette 1 of pST39, followed by subcloning of untagged FIH
WT/H199A or MBP-FIH WT/H199A into cassette 4. Bacteria lysates
were prepared, the protein complex purified by sequential MBP- and
Ni2+-affinity purification and analyzed as described above.
2.10. Biochemical analyses of the purified stable FIH-OTUB1 complex
Equal amounts of purified FIH-OTUB1 complex or albumin (fraction
V, Carl Roth GmbH + Co. KG, Karlsruhe, Germany) were either ex-
posed to 0.1 M NaOH, 10 mM NaOH, 10 mM HCl or 1 M NH2OH at pH 7
or 10, or left untreated. Following incubation for 1 h at 37°C, samples
were neutralized using corresponding amounts of NaOH or HCl and
incubated for further 15min at 37°C and analyzed by SDS-PAGE as
described above.
2.11. Immunoprecipitation
Immunoprecipitation was performed as previously described [17].
Briefly, for native conditions, cells were lysed with 150mM NaCl,
20mM Tris-HCl (pH 7.5), 1 mM MgCl2, 1% Triton X-100, supplemented
with protease inhibitor cocktail (Sigma-Aldrich). For denaturing con-
ditions, cells were scraped in PBS and centrifuged for 3min at 200 g.
The cell pellet was resuspended in the same lysis buffer but supple-
mented with 1% SDS and 0.75 U/μl benzonase (Sigma-Aldrich), boiled
for 10min and the cellular solutes were cleared by centrifugation at
21,000 g and 4°C for 5min. Cell lysates were incubated with anti-FLAG
M2 antibody-coupled beads (Sigma-Aldrich) or anti-V5 agarose affinity
gel (Sigma-Aldrich) at 4°C for 1 h. Agarose beads were washed twice
with lysis buffer and twice with washing buffer (150mM NaCl, 20mM
Tris-HCl pH 7.5, 1mM MgCl2). For analysis by MS, the beads were
treated as described below. For analysis by immunoblotting, the beads
were resuspended in non-reducing loading buffer (50mM Tris-HCl pH
6.8, 6% glycerol, 2% SDS, 0.01% bromophenol blue) and boiled for
5min. 10mM DTT was added to the supernatant and boiled for further
5min. For endogenous FIH-specific immunoprecipitation, anti-FIH an-
tibody or anti-β-actin control antibody was bound to protein G-se-
pharose (GE Healthcare) for 1 h at RT and incubated with non-dena-
tured cell lysates over night at 4°C. Beads were washed and precipitated
proteins were analyzed by immunoblotting.
2.12. OTUB1 deubiquitinase (DUB) assay
Purified enzymes at the indicated concentration were incubated
with 600 nM K48-tetraubiquitin (K48-Ub4; Boston Biochem, Cambrige,
MS, USA) at 37°C in the presence or absence of 25 μMUBCH5B (Enzo
Life Science, Inc., Farmingdale, NY, USA). K48-Ub4 alone was used as
negative control. The reaction was stopped by addition of 5x loading
dye and samples were incubated for 20min at RT prior to immunoblot
analysis.
2.13. Mass spectrometry (MS) analysis of the FIH-OTUB1 HD
For analysis of the stable FIH-OTUB1 complex, immunoprecipitated
proteins from HEK293 cells were separated by SDS-PAGE. Bands were
cut from the Coomassie-stained gel, chopped into small pieces and
washed twice with 100mM NH4HCO3, 50% acetonitrile and once with
acetonitrile. Digestion with 50 ng trypsin (sequencing grade; Promega,
Madison, WI, USA) was performed in buffered conditions (10mM Tris-
HCl pH 8.2, 2mM CaCl2) for 30min at 60°C in a microwave oven
(Discover System, CEM Corporation, Matthews, NC, USA). The super-
natant was collected and lyophilized in a SpeedVac (Thermo Fisher
Scientific). For liquid chromatography-tandem MS (LC-MS/MS) ana-
lysis, the samples were dissolved in 20 μl 0.1% formic acid and 3 μl
were analyzed on a nanoAcquity ultra performance liquid chromato-
graphy (UPLC) column (Waters Corporation, Milford, MA, USA) con-
nected to a Q Exactive mass spectrometer (Thermo Fisher Scientific)
equipped with a Digital PicoView source (New Objective, Inc., Woburn,
MA, USA). Peptides were trapped on a Symmetry C18 trap column
(5 μm, 180 μm×20mm, Waters Corporation) and separated on a
BEH300C18 column (1.7 μm, 75 μm×150m, Waters Corporation) at a
flow rate of 250 nl/min using a gradient from 1% solvent B (0.1%
formic acid in acetonitrile)/99% solvent A (0.1% formic acid in water)
to 40% solvent B/60% solvent A within 30min. The mass spectrometer
was set to data dependent analysis, precursor scan range 350–1500m/
z, resolution 70,000, maximum injection time 100ms, threshold 3e6.
The fragment ion scan range was 200–2000m/z, resolution 35,000,
maximum injection time 120ms, threshold 1e5. Proteins were identi-
fied using the Mascot search engine (Matrix Science; Version 2.5.1.3.).
Mascot was set up to search the human SwissProt database assuming
the digestion enzyme trypsin. Mascot was searched with a fragment ion
mass tolerance of 0.030 Da and a parent ion tolerance of 10.0 ppm.
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Oxidation of methionine was specified in Mascot as a variable mod-
ification. Scaffold (Proteome Software Inc., Version 4.8.6) was used to
validate MS/MS based peptide and protein identifications. Peptide
identifications were accepted if they achieved a false discovery rate
(FDR) of less than 0.1% by the Scaffold Local FDR algorithm. Protein
identifications were accepted if they achieved an FDR of less than 1.0%
and contained at least 2 identified peptides. The number of peptides
was determined by the number of spectra identifying specific peptide
sequences for each protein.
2.14. Mass spectrometry analysis of denatured and non-denatured FIH
interactomes
For analysis of the stable FIH interactome by label-free quantifica-
tion (LFQ), human FIH-V5 or tandem EGFP was expressed in
HEK293 cells, and cells were lysed in native or denaturing conditions as
described above. Following V5-specific IP, the beads were resuspended
in 45 μl digestion buffer (10mM Tris-HCl pH 8.2, 2mM CaCl2) and the
proteins were on-bead digested using 5 μl of 100 ng/μl trypsin in 10mM
HCl (sequencing grade; Promega) in a microwave oven for 30min at
5W and 60°C. The supernatants were transferred into new tubes and
the beads were additionally digested for 3 h at room temperature. The
beads were washed with 100 μl TFA-buffer (0.1% TFA, 10mM Tris,
2 mM CaCl2) and all supernatants were combined, lyophilized, re-
solubilized in 25 μl of 3% acetonitrile, 0.1% formic acid spiked with iRT
peptides (Biognosys AG, Schlieren, CH), centrifuged at 20,000 g for
10min and analyzed on a Q Exactive mass spectrometer coupled to a
Nano Easy 1000 liquid chromatography system (Thermo Fisher
Scientific). Solvent composition was 0.1% formic acid for channel A
and 0.1% formic acid in acetonitrile for channel B. For each sample, 4 μl
of peptides were loaded on a commercial Acclaim PepMap Trap Column
(75 μm×20mm, Thermo Fisher Scientific) followed by a PepMap
RSLC C18 Snail Column (75 μm×500mm; Thermo Fisher Scientific).
The peptides were eluted at a flow rate of 300 nL/min by a gradient
from 5 to 22% B in 79min, 32% B in 11min and 95% B in 10min.
Samples were acquired in a randomized order. The mass spectrometer
was operated in data-dependent mode (DDA), acquiring a full-scan MS
spectra (300−1700m/z) at a resolution of 70,000 at 200m/z after
accumulation to a target value of 3,000,000, followed by higher-energy
collision dissociation (HCD) fragmentation on the twelve most intense
signals per cycle. HCD spectra were acquired at a resolution of 35,000
using a normalized collision energy of 25 and a maximum injection
time of 120ms. The automatic gain control (AGC) was set to 50,000
ions. Charge state screening was enabled and singly and unassigned
charge states were rejected. Only precursors with intensity above 8300
were selected for MS/MS (2% underfill ratio). Precursor masses pre-
viously selected for MS/MS measurement were excluded from further
selection for 30 s, and the exclusion window was set at 10 ppm. The
samples were acquired using internal lock mass calibration on m/z
371.1010 and 445.1200. The acquired raw MS data were processed by
MaxQuant (Version 1.6.1) [42], followed by protein identification
using the integrated Andromeda search engine [43]. Spectra were
searched against a UniProt Homo Sapiens (taxonomy 9606) reference
proteome (canonical version from 2016 to 12-09), concatenated to its
reversed decoyed fasta database and common protein contaminants.
Carbamidomethylation of cysteine was set as fixed, while methionine
oxidation and N-terminal protein acetylation were set as variable
modifications. MaxQuant Orbitrap default search settings were used.
Enzyme specificity was set to trypsin/P. For LFQ, MaxQuant default
settings were applied. In the MaxQuant experimental design template,
the biological and biochemical replicates were grouped into non-ad-
jacent fractions, to allow match-between-runs within but not between
conditions. Each file was treated as a separate experiment to obtain
individual quantitative values. Protein fold changes were computed
based on intensity values reported in the proteinGroups.txt file. A set of
functions implemented in the R package SRMService (http://github.
com/protViz/SRMService [44]) was used to filter for proteins with 2 or
more peptides, with quantification in at least 4 samples, and to nor-
malize the data with a modified robust z-score transformation and to
compute p-values using the t-test with pooled variance. The MS pro-
teomics data were handled using the local laboratory information
management system (LIMS) [45]. FIH-specific interactors had an
average LFQ intensity of the four biological replicates of at least 2-fold
over control (EGFP) and were statistically significantly different
(p < 0.05). The obtained lists of FIH-specific interactors were analyzed
for overlaps using Excel (Microsoft). Functional annotation was per-
formed via the PANTHER database (www.pantherdb.org). For com-
parison of relative intensities, individual LFQ intensities were normal-
ized to the average intensity of FIH in the samples with ectopic FIH
expression.
2.15. Primer sequences
The designed primers for the site-directed mutagenesis of human
OTUB1 were as follows (fwd, forward primer; rev, reverse primer):
S16A - fwd: 5′-accttcggagtcggcgcccagcggctcc-3′, rev: 5′-ggagccgctg-
ggcgccgactccgaaggt-3'.
S18A - fwd: 5′-gttaacaccttcggcgtcgctgcccagcg-3′, rev: 5′-cgctgg-
gcagcgacgccgaaggtgttaac-3'.
S16/18A - fwd: 5′-ttaacaccttcggcgtcggcgcccagcggctcc-3′, rev: 5′-gga-
gccgctgggcgccgacgccgaaggtgttaa-3'.
C23A - fwd: 5′-ttcatcataggccagagcgttaacaccttcggagtcgc-3′, rev: 5′-
gcgactccgaaggtgttaacgctctggcctatgatgaa-3'.
C23S fwd: 5′-cataggccagagagttaacaccttcggagtcg-3′, rev: 5′-cgactcc-
gaaggtgttaactctctggcctatg-3'.
C91A – fwd: 5′-gaaagcccgatagaaagcgttgccgtcaggcctg-3′, rev: 5′-cagg-
cctgacggcaacgctttctatcgggctttc-3'.
C91S – fwd: 5′-aaagcccgatagaaagagttgccgtcaggcc-3′, rev: 5′-
ggcctgacggcaactctttctatcgggcttt-3'.
Primers designed for the cloning of OTUB1 WT and N22A into
pET3a -
fwd: 5′-actgcatatggcggcggaggaacctcagga-3′, rev: 5′-acgtggatccc-
tatttgtagaggatatcgt-3'.
Primers designed for the cloning of FIH WT and H199A into pET3a -
fwd: 5′-acgtcatatggcggcgacagcggcgga-3′, rev: 5′-acgtggatccctagttg-
tatcggcccttgatca-3'.
Primers designed for the cloning of His-OTUB1 WT and N22A into
pET3a - fwd 5′-acgtcatatgtcgtactaccatcaccatca-3′, rev 5′-acgtagatc-
tctatttgtagaggatatcgt-3'.
Primers designed for the cloning of MBP into pET3a-FIH:
fwd 5′-acgtcatatgaaaatcgaagaaggtaaact-3′, rev 5′-actgcatatgggcg-
ccctgaaaatacagg-3'.
2.16. Statistical analysis
For the analysis of the significance of difference between two data
points, Student's t-test was applied. For comparison of more than two
data points, one-way or two-way ANOVA followed by Tukey post-test
was applied. P values < 0.05 were considered statistically significant.
2.17. Data availability
The MS proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE [46] partner repository
with the dataset identifier PXD011252.
3. Results
3.1. FIH and OTUB1 form a covalently linked protein complex
Following our previous observations of FIH-dependent
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hydroxylation of OTUB1 on N22 [17,18], we here investigated the in-
terplay between FIH and OTUB1 in more detail by immunoprecipitation
(IP) of endogenous FIH. Intriguingly, we detected an unexpected signal
in immunoblots with antibodies derived against FIH as well as OTUB1
(Fig. 1A; marked with “X”). Protein X demonstrated a larger molecular
weight than FIH or OTUB1 alone and its signal intensity was decreased
following OTUB1 knockdown and abolished by iron chelation with
desferrioxamine (DFX) (Fig. 1A). Protein X was also detectable using
antibodies against ectopically (plasmid-based) expressed tagged FIH
and OTUB1 (Figs. 1B and S1A). Protein X was subsequently investigated
using ectopically expressed tagged OTUB1 and FIH to allow detailed
analyses with complete control over the experimental conditions. Pro-
tein X signal intensity was proportional to OTUB1 protein levels, while
mutation of the OTUB1 hydroxylation site (N22A) abrogated it
(Fig. 1B). Mass spectrometry (MS) identified equimolar amounts of FIH
and OTUB1 peptides in protein X (Fig. S1B). Taken together, these re-
sults are consistent with a heterodimer (HD) consisting of FIH and
OTUB1. Furthermore, the FIH-OTUB1 HD was also detected in MCF7
(breast cancer) and Hep3B (liver cancer) cells (Figs. S1C and S1D),
indicating that HD formation is cell type independent.
HD formation was resistant to denaturing SDS-PAGE, consistent
with a possible covalent FIH-OTUB1 conjugation. This was further
analyzed following the strategy of the original characterization of the
covalent bond between ubiquitin (Ub) and substrate proteins [47]. The
complex was resistant to chaotropic urea-PAGE (Fig. 1C). The HD was
also not disrupted by high concentrations of the reducing agents β-
mercaptoethanol (βME) (Fig. 1A (lysates), 1D, 1E (lysates) and S1E),
iodoacetamide (Fig. 1B) and DTT (Fig. 1A (IPs) and 1E (IPs)), excluding
disulfide bonds as possible connection. For the further assessment of the
nature of this conjugation, the HD was purified from bacteria. The
purified complex was exposed to high (0.01 and 0.1M NaOH) and low
pH (10mM HCl) as well as to 1M hydroxylamine (pH 7 and 10). NaOH
treatment disrupts ester bonds and hydroxylamine disrupts thioester
bonds at pH 7 and oxyester bonds at pH 10 [48,49]. Amide bonds are
resistant to these conditions [48,49]. Low pH disrupts non-covalent
bonds and esters. A specific disruption of the bond between FIH and
OTUB1 in the HD should yield a decrease of HD levels with simulta-
neous increase in monomeric FIH and OTUB1. However, no increase in
monomeric FIH or OTUB1 levels occurred when the HD decreased
(Fig. 1D). In addition, when the heterodimer was reduced, the BSA
control was decreased to a comparable level as well (Figs. 1D and S1F).
This indicates that the observed decreases in the HD were due to gen-
eral effects on protein stability and not due to specific disruption of the
FIH-OTUB1 conjugation. Hence, FIH and OTUB1 are covalently
Fig. 1. Characterization of the FIH-
OTUB1 conjugation. (A) Immunoblot
analysis of endogenous FIH IP detected the
unexpected protein signal (“X”), which was
insensitive to 858mM β-mercaptoethanol
(βME) and 10mM DTT. The same antibody
was used for the FIH IP and subsequent FIH
immunoblotting and the anti-β-actin anti-
body was derived from the same species as
the anti-FIH antibody, leading to the de-
tection of fragments of the IP antibodies
(ab; highlighted by open arrows). Black ar-
rows highlight specific signals of the in-
dicated proteins. (B) The intensity of X de-
tected by immunoblotting of cell lysates
was proportional to FIH and wildtype
OTUB1 (WT) levels, as seen with ectopic
FLAG-OTUB1 expression, knockdown and
ectopic mutant OTUB1 (N22A) expression.
Protein signal X was insensitive to 100mM
iodoacetamide, the only agent present that
disrupts disulfide bonds. (C) Investigation
of the resistance of the FIH-OTUB1 HD in-
teraction to a chaotropic agent by urea-
PAGE followed by immunoblotting. (D)
Investigation of the effect of treatments
disrupting thioesters and oxyesters using
purified HD. The samples were analysed by
Coomassie-stained SDS-PAGE, which in-
cluded boiling in the presence of 858mM
βME during sample preparation. (E)
Residues of the FIH interaction site of
OTUB1 were mutated and their relevance
for HD formation investigated by ectopic
expression of the mutated proteins and anti-
FLAG-IP. All samples were boiled in the
presence of 858mM βME or 10mM DTT as
indicated followed by immunoblotting exp,
exposure; HD, heterodimer; M, monomer;
ect, ectopic (plasmid-based) expression;
end, endogenous protein. The data re-
present (A) two, (C, D, E (IPs)) three, (B)
four or (E (lysates)) six independent ex-
periments.
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attached within the HD and this covalent linkage fulfils all biochemical
criteria of an amide bond.
OTUB1 N22A mutation abrogated HD formation (Fig. 1B) as well as
the non-covalent interaction between FIH and OTUB1 (Fig. 1E, S2A and
S2B). For a further investigation of the relevance of OTUB1 N22 for HD
formation, additional mutations of OTUB1 were introduced within its
FIH interaction region (S16, S18, C23) or catalytic domain (C91;
leading to a catalytically inactive OTUB1 mutant [21]). Analysis by IP
showed that C91 was dispensable, demonstrating that HD formation
occurs independent of OTUB1 catalytic activity. The input as well as the
FLAG-specific IPs showed that beside N22 also C23 mutation abrogated
both the HD and the non-covalent FIH:OTUB1 interaction, while mu-
tations of S16 and/or S18 decreased the HD and the FIH:OTUB1 in-
teraction by roughly 50% (Fig. 1E, S2C and S2D). Overall, these results
demonstrate that mutations of the OTUB1 hydroxylation site and of its
FIH interaction site affect FIH-OTUB1 HD levels and that both are ne-
cessary for optimal interaction and HD formation. In addition, they
indicate that the OTUB1 amino acid directly involved in the conjuga-
tion with FIH is either N22 or C23.
3.2. FIH-dependent FIH-OTUB1 heterodimer formation is a hypoxia-
regulated mechanism
While OTUB1 enzymatic activity was dispensable for HD formation,
the OTUB1 hydroxylation site as well as the FIH interaction site were
necessary. Therefore, we hypothesized that FIH catalyzes the formation
of the putative covalent bond. In agreement with this hypothesis, hy-
poxia (0.2% O2), a 2-oxoglutarate (2-OG) competitor (dimethylox-
alylglycine, DMOG) and the iron chelator DFX prevented HD formation
(Fig. 2A). The PHD-specific inhibitor FG-4592 (roxadustat) [50] did not
affect HD levels (Fig. 2A). Accordingly, knockdown of endogenous FIH
with parallel expression of a catalytically inactive FIH mutant (H199A)
[31] completely abolished formation of the HD (Fig. 2B). Overall, these
results demonstrated that FIH enzymatic activity is required for cova-
lent bond formation. A possibly limiting availability of FIH co-factors in
cell culture affecting the FIH catalytic cycle could be excluded (Fig.
S2E).
In order to investigate the sensitivity of HD formation to oxygen
availability, 8 different oxygen levels were used in the range of
18.5%–0.2% O2. HIF-1α and HIF-2α stabilization were determined as
biological readout for the obtained level of hypoxia and for the com-
parison with the PHD sensitivity. We observed an unusually high hy-
poxia sensitivity with an EC50 of 4.1% O2, which was even higher than
the hypoxia sensitivity of the PHD-dependent HIF-1α and HIF-2α sta-
bilization with EC50 values of 2.15% and 3.5% O2, respectively (Fig. 2C
and D). Of note, this is in stark contrast to the known hypoxia sensi-
tivity for FIH-dependent HIF-1α hydroxylation, which is below 1% O2
[51,52].
Taken together, our results demonstrate that FIH catalyses HD for-
mation with OTUB1, which is remarkably sensitive to changes in
oxygen availability within the physiologically relevant range, sug-
gesting a function in oxygen-dependent signaling.
3.3. The FIH-OTUB1 heterodimer forms co-translationally and is
extraordinarily stable
As the next step, the stability of the HD was analyzed in cellulo. First,
transiently transfected cells were allowed to form the HD for 24 h with
subsequent inhibition of further HD formation by exposing these cells to
0.2% O2. The HD showed a pronounced stability with significant de-
creases in HD levels after only 24 h (Figs. 3A and S3A).
For the investigation of the HD formation time, HEK293 cells were
transfected with FIH and OTUB1 expressing plasmids for 5 h and sub-
sequently incubated for 16 h in 0.2% O2 in order to inhibit FIH activity
to express both FIH and OTUB1 without HD formation (Fig. S3B).
Media was replaced with normoxic media for instantaneous re-oxyge-
nation and the time of HD formation was analysed (Fig. S3B). HD for-
mation was unexpectedly slow with a half-maximal level after 2.5 h,
reaching a level comparable with normoxia after 8.7 h (Figs. 3B and
S3C; values calculated from Fig. S3C). Re-oxygenation following hy-
poxia leads to active FIH within approximately 1min [52], which can
therefore not explain the slow HD formation. Hence, we assumed that a
Fig. 2. Hypoxia sensitivity of the FIH-
dependent FIH-OTUB1 heterodimer for-
mation. (A) Heterodimer (HD) formation
was sensitive to hypoxia (Hx, 0.2% O2),
DMOG and DFX, but not to the PHD-specific
inhibitor FG-4592. (B) Immunoblotting of
cell lysates with the indicated ectopic ex-
pressions. The H199A FIH mutant is cata-
lytically inactive and was incapable of
forming the HD. (C) Hypoxia sensitivity of
HD formation in comparison with HIF-1α
and HIF-2α stabilization following 24 h of
incubation at the indicated O2 levels. (D)
Quantification of the experiment described
in (C) and calculation of the oxygen sensi-
tivity of HD formation and HIF-1α and HIF-
2α stabilization based on this quantifica-
tion. Nx, normoxia; M, monomer. Data are
shown as mean ± SEM from four in-
dependent experiments or are re-
presentative for (A, B) three or (C) four in-
dependent experiments.
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mechanism independent of FIH enzymatic activity was involved and
investigated if HD formation occurred co-translationally using cyclo-
heximide (CHX; Fig. S3B). Simultaneous addition of CHX with the start
of the re-oxygenation had no effect on the formation of the HD (Fig. 3C;
Re-ox ctrl vs. Re-ox CHX). However, the simultaneous start of two
different treatments such as CHX and re-oxygenation can make it dif-
ficult to interpret the result due to different kinetics involved. There-
fore, we also included samples in which we pre-treated the cells for 1 h
with CHX prior to the start of re-oxygenation to allow for an efficient
inhibition of translation at the time of re-oxygenation. In these samples,
HD formation was markedly reduced after 6 h of re-oxygenation
(Fig. 3C; Re-ox ctrl vs. Re-ox CHX pre), indicating that translation might
be important for HD formation. Interestingly, purified FIH and OTUB1
did not form the HD under cell-free conditions (data not shown).
However, a bicistronic expression vector [33] for FIH and OTUB1 (Fig.
S3D), expressing both proteins in the same bacterium, resulted in HD
formation which was dependent on the presence of the OTUB1 N22
hydroxylation site and on active FIH (H199A abrogated HD formation)
(Fig. 3D). Co-inoculation of bacterial cultures that expressed either FIH
or OTUB1 did not lead to detectable HD formation (Fig. S3E). Taken
together, these results strongly suggest that HD formation occurs co-
translationally.
3.4. The FIH-OTUB1 HD is part of a native FIH:FIH-OTUB1 heterotrimer
The active form of FIH is a non-covalent FIH:FIH homodimer [53].
Therefore, we sought to investigate, if both FIH proteins of the homo-
dimer form a covalent bond with OTUB1 and if HD formation interferes
with the interaction of the FIH proteins within the FIH homodimer.
Following native gel electrophoresis, ectopic FIH-V5 expression alone
showed two bands in the immunoblot, which corresponded to mono-
meric FIH and homodimeric FIH, as homodimeric FIH was not detect-
able anymore after denaturation of the same sample (Fig. 4A). With
ectopic FIH-V5 and FLAG-OTUB1 co-expression, a complex was de-
tectable that was composed of FIH and OTUB1 (detected with both
antibodies) and moved slower in the electric field than the FIH homo-
dimer (Fig. 4A). Next, the composition of this complex was analyzed in
a second denaturing dimension following native gel electrophoresis.
Alongside the HD, a further signal was observed in the anti-V5 im-
munoblot at the same molecular weight as the V5 signal obtained from
FIH-V5 expression alone (Fig. 4B). This revealed that the native com-
plex contained an additional, non-covalently bound FIH protein. Non-
covalently interacting (monomeric) OTUB1 was not detected within the
complex (Fig. 4B). In summary, only covalently linked OTUB1 was
present in the complex combined with a covalently linked FIH and a
second, non-covalently interacting FIH. Hence, in cellulo a FIH:FIH-
OTUB1 heterotrimer (HT) is formed.
3.5. Covalent complex formation with FIH regulates OTUB1 enzymatic
activity
To assess possible functional consequences of HT formation for
OTUB1 enzymatic activity (hydrolysis of K48-linked Ub chains),
monomeric free OTUB1 and the native HT were purified from bacterial
lysates (Figs. S4A and S4B). To account for a small contamination of the
HT by monomeric OTUB1, indicating that non-covalently bound
OTUB1 was co-purified, molar concentrations of the control (mono-
meric OTUB1) were matched with the contamination. Within the HT
sample, there was a significant increase in cleavage of K48-Ub chains in
comparison to monomeric OTUB1 following 5min of incubation, as
shown by significant decreases in Ub4 chains paralleled by significant
increases in Ub3 chains (Fig. 5A and B). This demonstrated a higher
deubiquitinase activity within the HT sample over monomeric OTUB1,
which could only be derived from the HT itself. Hence, OTUB1 enzy-
matic activity was maintained in the HT. Interestingly, at later time
points this activity was decreased in comparison to monomeric OTUB1
(Fig. 5A and B).
Interaction of the OTUB1 N-terminus with uncharged E2s (such as
UBCH5B) increases OTUB1 activity towards K48-ubiquitin chains by
stabilizing the structure of an OTUB1 Ub-binding site [26]. Because the
OTUB1 N-terminus also contains the FIH interaction site, we in-
vestigated if the stimulating effect of UBCH5B on OTUB1 enzymatic
activity was affected by HT formation. The activity of purified mono-
meric OTUB1 was strongly increased in the presence of UBCH5B, as
demonstrated by a faster turnover of K48-linked Ub4 into smaller Ub
chains when UBCH5B was present (Fig. 5C and D and Fig. S4C). In
contrast, HT-dependent cleavage of Ub4 chains was reduced in the
presence of UBCH5B in comparison to HT alone, as shown by higher
residual levels of Ub4 chains in samples containing both the HT and
UBCH5B compared to samples containing the HT alone (Fig. 5C and D
Fig. 3. Co-translational formation of the
extraordinarily stable FIH-OTUB1 HD.
(A) Following ectopic expression of the in-
dicated proteins, the FIH-OTUB1 hetero-
dimer (HD) was allowed to form for 24 h
prior to the analysis of the HD stability in
hypoxia when FIH is inhibited and no ad-
ditional HD can be formed. (B) HD forma-
tion kinetics and (C) HD formation during
translation inhibition by cycloheximide
(CHX) according to the experimental setups
described in Fig. S3B. Re-Ox CHX, addition
of CHX at the same time as re-oxygenation
was started; Re-Ox CHX pre, pre-incubation
of cells with CHX for 1 h prior to the start of
re-oxygenation. (D) Bicistronic expression
of the indicated His-OTUB1-MBP-FIH in
E.coli followed by immunoblot analysis.
Time points indicate the time after induc-
tion of protein production by addition of
isopropyl-ß-D-thiogalactoside (IPTG). Nx,
normoxia; M, monomer. Data are re-
presentative for three independent experi-
ments throughout.
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and Fig. S4C). This demonstrated that UBCH5B had the opposite effect
on OTUB1 activity when OTUB1 was bound by FIH (forming the HT)
than on monomeric OTUB1.
These results show that OTUB1 maintains its enzymatic activity
within the heterotrimeric complex with FIH, but the important reg-
ulation of its activity by the E2 enzyme UBCH5B is inverted, demon-
strating a functional effect of FIH:FIH-OTUB1 HT formation.
3.6. FIH forms denaturation resistant complexes with a specific subset of its
interactome
During our analyses, we observed further higher molecular weight
bands in addition to the HD that were also detected with an antibody
against FIH (Fig. S5A). Intriguingly, these bands disappeared when FIH
activity was inhibited (Fig. S5A). This indicated that FIH-dependent
covalent bond formation was not restricted to OTUB1. For the in-
vestigation of such potential further covalent complexes formed by FIH,
we utilized an assay previously described for the discrimination of
covalent and non-covalent ubiquitin interactions [54]. In this assay, the
FIH-OTUB1 HD was pulled down under denaturing conditions without
non-covalently interacting FIH (Fig. 6A). When FIH-V5 was expressed
alone, the same approach showed several high molecular weight com-
plexes, of which some were maintained under denaturing conditions
(”+SDS”) (Fig. 6B). This further indicated that a subset of the FIH
Fig. 4. FIH:FIH-OTUB1 heterotrimer for-
mation. Analysis of the composition of the
covalently linked FIH-OTUB1 complex by
(A) blue native-PAGE (first dimension, 1D)
following ectopic expression in
HEK293 cells and by (B) SDS-PAGE as
second dimension (2D). *, FIH-OTUB1 het-
erodimer; x, FIH homodimer; y, FIH
monomer; arrows 1–3, monomeric FIH ori-
ginating from FIH monomers [1], FIH:FIH
homodimers [2] or the FIH:FIH-OTUB1
heterotrimer [3]. Data are representative
for three independent experiments
throughout.
Fig. 5. UBCH5B-dependent regulation of
OTUB1 DUB activity in the FIH:FIH-
OTUB1 heterotrimer. (A-D) Comparison of
the OTUB1 enzymatic activity in purified
monomeric OTUB1 and in the FIH:FIH-
OTUB1 heterotrimer (HT) in (A, B) the ab-
sence or (C, D) presence of the E2 protein
UBCH5B using (A, C) a DUB assay and (B,
D) quantification. (D) The relative levels of
Ub4 chains were quantified in each sample
of the experiment described in (C).
Quantified Ub4 chain amounts in the sam-
ples containing His-OTUB1 alone were
subtracted from the quantified Ub4 chain
amounts in samples with His-
OTUB1 + UBCH5B (clear bars). The same
analysis was carried out for the His-MBP-
HT: quantified amounts of Ub4 chains in
samples with His-MBP-HT alone were sub-
tracted from the quantified amounts in the
samples containing His-MBP-HT +
UBCH5B (grey bars). DUB, indicates the
deubiquitinases OTUB1 or HT, respectively.
HD, heterodimer; M, monomer, Ubn, K48-
linked ubiquitin chains with n number of
Ub proteins; ns, not significant. Data are
shown as mean + SEM from three in-
dependent experiments or are re-
presentative for three independent experi-
ments. *, p < 0.05; **, p < 0.01; ***,
p < 0.001 by two-way ANOVA followed
by Tukey post-test.
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interactome forms covalent complexes with FIH similar to OTUB1. MS
identified 71 proteins that interacted with FIH following native lysis (”-
SDS”), while 375 proteins were observed following IP from denatured
cell lysates (Fig. 6C). The higher number of co-precipitants in the IP
from denatured cell lysates was surprising, but denaturing lysis will
lead to the extraction of more proteins, which could explain the dif-
ference in the number of detected proteins. Thirteen FIH interactors
were present under denaturing as well as native conditions, including
OTUB1 (Fig. 6C and D and Fig. S5B). The interactomes covered a broad
spectrum of different biological processes (Fig. S5C). Among the 12
novel candidates for covalent complex formation, the previously de-
scribed FIH interactors IκBβ and CDK1 were present [13,17]. These
results demonstrate that FIH forms stable complexes with a subset of its
interactome.
4. Discussion
The formation of protein complexes is the basis for cellular pro-
cesses and functions [55]. Hence, the understanding of protein complex
formation is fundamental for our understanding of health and disease.
Cellular oxygen sensing is vital for cells in order to be able to monitor
oxygen availability in their local microenvironment and to adjust to
changes accordingly [3]. In this study, we provide insights into a pre-
viously unknown cross-talk between FIH and OTUB1 through amide
bond formation catalysed by FIH, with unprecedented oxygen sensi-
tivity and with functional relevance for OTUB1, regulating its K48-Ub
chain cleavage activity. The covalent FIH-OTUB1 HD formation may
represent an alternative molecular mechanism for the cellular adapta-
tion to oxygen changes over longer time periods, linking oxygen sensing
and deubiquitinase activity. Furthermore, we provided results in-
dicating that FIH-dependent covalent bond formation is not exclusive
for OTUB1.
The covalent bond of the FIH-OTUB1 HD fulfils all biochemical
criteria of an amide bond [47–49,56,57]. FIH enzymatic activity was
necessary for HD formation and hence FIH appears to have amide
synthase activity. This activity required the same co-factors and co-
substrates as FIH-dependent hydroxylation. But in contrast to amide
bond formation in the ubiquitin system, FIH is not known to utilize
ATP. Furthermore, the catalyzing protein (FIH) attaches itself instead of
a third moiety, such as an ubiquitin or a hydroxyl group. Hence, the
proposed FIH amide synthase activity on OTUB1 would be based on an
unprecedented molecular mechanism.
FIH can oxidize hydrophilic, hydrophobic, acidic, basic, polar and
neutral amino acid side chains and FIH may catalyze the formation of
β–oxo-histidine and dehydrohistidine [58–60]. This demonstrates that
FIH catalytic activity is highly promiscuous and that FIH may be cap-
able of catalyzing more than asparagine hydroxylation. In our experi-
ments, point mutations of OTUB1 indicated that N22 and C23 are ne-
cessary for HD formation. Cysteines such as C23 can form disulfide
bonds or thioesters, but both types of covalent bonds were excluded by
our analyses. N22 can be hydroxylated by FIH [18], demonstrating that
N22 is accessible for FIH catalytic activity. Therefore, N22 is likely the
OTUB1 amino acid that is involved in the covalent bond formation.
However, peptides corresponding to the suspected regions of FIH-
OTUB1 HD formation could not be detected by MS, which is likely due
to the unknown molecular weight of these unique peptides, and ex-
cludes a direct examination of the nature of the FIH-OTUB1 bond.
Interestingly, asparagine can non-enzymatically form succinimide
intermediates, which lead to amide bond formations with lysine re-
sidues during aging [61]. Furthermore, in specific bacterial proteins
asparagine can auto-catalytically form succinimide intermediates that
lead to amide bond formation with lysyl residues, provided that an
additional glutamate or aspartate is present within a hydrophobic
pocket [62]. FIH contains an aspartate (D201; iron coordination) and a
Fig. 6. Denaturing condition-resistant
FIH interactome composition. (A)
Following ectopic expression of the in-
dicated proteins, HEK293 cells were lysed
under native or denaturing (boiling in 1%
SDS) conditions followed by anti-FLAG IP
and immunoblot analysis. HD, heterodimer;
M, monomer; ab, antibody. (B) Following
ectopic expression of either FIH-V5 or
tandem EGFP, HEK293 cells were lysed as
described in (A) followed by anti-V5 IP and
immunoblot analysis. Arrow heads indicate
protein signals that were only detected fol-
lowing IP from native samples (-SDS). *,
protein signals detected in IPs from both
conditions (native and denatured ly-
sates); exp, exposure. (C) Following the
same sample preparation as in (B), the
samples were analysed by MS. Venn dia-
gram displaying the overlap between FIH
interactors under native (-SDS) and dena-
turing (+SDS) conditions. (D) Rank order
of the 13 proteins interacting with FIH
under both conditions shown in (C), ac-
cording to the relative label free quantifi-
cation (LFQ) intensity following IP in the
presence of SDS and normalized to FIH pull-
down. Data are shown as mean ± SEM.
HD, heterodimer; M, monomer; ab, anti-
body; exp, exposure. Data are shown as
mean ± SEM from (C, D) four biological
replicates or are representative for (A) three
or (B) one independent experiment. (B–D)
Samples were processed in parallel and only
differ in the analysis (immunoblot or MS).
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lysyl residue (K214; 2-OG coordination) within its active center
[63,64]. Unfortunately, the involvement of K214 in covalent bond
formation cannot be assessed since the enzymatic activity of FIH is
likely lost following K214 mutation.
FIH-dependent asparagine hydroxylation of HIF still occurs at lower
oxygen levels than PHD dependent prolyl hydroxylation [52,65]. Here,
we report an even higher oxygen sensitivity for FIH-mediated HD for-
mation than for PHD-mediated HIFα destabilization. The half-maximal
oxygen concentration (gas phase) for HD formation was determined as
4.1% O2, which is in stark contrast to the previously determined sen-
sitivity for FIH-dependent HIFα hydroxylation, being below 1% O2
[51,52]. Interestingly, the oxygen sensitivity of FIH-dependent hydro-
xylation depends on the used substrate and its length [66,67]. There-
fore, it is likely that the here observed unprecedentedly high oxygen
sensitivity of FIH is encoded within the interacting peptide of the spe-
cific substrate.
Functionally, OTUB1 maintained enzymatic activity within the
FIH:FIH-OTUB1 HT, while the regulation of its activity by UBCH5B was
affected. OTUB1 enzymatic activity is regulated by E2 enzymes de-
pendent on the presence of free mono-Ub and whether the E2 is charged
with a covalently attached Ub. Mono-Ub in combination with Ub-
charged E2 enzymes inhibits OTUB1 enzymatic activity due to inter-
action of the Ub of the charged E2 enzyme with an Ub binding site at
the OTUB1 N-terminus and the interaction of the free mono-Ub with a
second Ub binding site, preventing OTUB1 from binding its substrate
(K48-linked Ub chains) [23,26,27]. Uncharged E2 enzymes in turn
stimulate OTUB1 activity by stabilizing the structure of the N-terminal
Ub-binding site that is disordered in the apoenzyme [21,26,27]. When
we assessed if OTUB1 DUB activity was preserved within the HT (in the
absence of UBCH5B), we observed an initial increase of OTUB1 activity
at 5min, which decreased in comparison to non-complexed OTUB1 at
later time points, coinciding with an increased release of mono-Ub. An
E2 was not present, but FIH might mimic the effect of a charged E2
enzyme within the HT, as it also binds to the OTUB1 N-terminus. The
stimulation of OTUB1 activity by uncharged UBCH5B was inverted
when OTUB1 was complexed by FIH. This effect was again comparable
to the regulation of OTUB1 activity by a charged E2 enzyme, although
this time in the absence of free Ub. Overall, it seems likely that the
functional regulation of OTUB1 by covalently bound FIH:FIH is due to
its localization and its resemblance to an interacting charged E2 en-
zyme.
We observed that the formation of the FIH-OTUB1 heterodimer is
slow (within the range of several hours) combined with slow de-
gradation kinetics (up to 24 h). This is in stark contrast to the fast HIF-
1α stabilization and degradation kinetics (seconds to minutes) [68].
The fast HIF-1α kinetics is crucial for its role as the main transcription
factor for the cellular adaptation especially to acute changes in oxygen
levels. The observed slow formation and degradation kinetics of the
FIH-OTUB1 HD will make it insensitive to brief fluctuations of oxygen
levels (minutes to possibly a few hours). Hence, the FIH-OTUB1 com-
plex is likely not involved in acute but rather in chronic cellular
adaptations to hypoxia, providing a further set point for cellular oxygen
availability besides HIFα.
Interestingly, the monomeric prolyl-3-hydroxylase 2-OG and Fe(II)-
dependent oxygenase domain-containing protein 1 (OGFOD1) has been
shown to form an OGFOD1 activity-dependent SDS-PAGE resistant
complex with its substrate ribosomal protein S23 (RPS23) [69,70].
However, the oxygen sensitivity of the complex formation, a possible
functional consequence or the nature of the interaction remained un-
clear. Of note, a point mutation in RPS23 that impairs its hydroxylation
and stable complex formation with OGFOD1 has recently been linked to
ribosomopathy in humans [71], indicating that covalent HD formation
of hydroxylases with their substrates may be involved in human dis-
eases.
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Fig S1. Cell-type independent covalent FIH-OTUB1 HD formation. (A) Ectopic 
expression of FLAG-OTUB1 in combination with FIH-V5 led to the detection of protein 
signal “X” at 72 kDa with both anti-FLAG and anti-V5 antibodies. (B) MS analysis of protein 
X excised from a SDS-PAGE gel following IP from HEK293 cell lysates demonstrated that 
protein X contained both OTUB1 and FIH. (C, D) Detection of the heterodimer (HD) by 
immunoblotting in MCF7 breast adenocarcinoma (C) and Hep3B liver carcinoma cell lysates 
(D) with the indicated plasmid-dependent expressions and knockdowns. (E) Immunoblot 
analysis of HEK293 lysates with the indicated ectopic expression in the presence or absence 
of 858 mM β-mercaptoethanol (βME) and boiling. (F) Quantification of the experiment 
described in Fig 1D. M, monomer; ab, antibody; nsp, non-specific. Data are shown as mean + 
SEM from (F) three independent experiments or are representative for (B) one or (A, C-F) 
three independent experiments. Statistical analysis by two-way ANOVA followed by Tukey 
post-test (ns, not significant).  
3 
 
 
Fig S2. Formation of the FIH-OTUB1 HD depends on the OTUB1 hydroxylation site 
and FIH activity. (A) Immunoblotting following anti-FLAG IP of HEK293 lysates 
containing the indicated ectopically expressed proteins. (B) Quantification of monomeric FIH 
(M) and of the FIH-OTUB1 HD of the experiments shown in (A). (C, D) Quantification of 
the experiments shown in Fig 1E. (E) Immunoblot analysis of HEK293 cells following the 
addition of FIH co-factors/substrates or the iron chelator DFX. HD, heterodimer; M, 
monomer; ab, antibody. Data are shown as mean + SEM from (B, D) three or (C) six 
independent experiments or are representative of (A, E) three independent experiments. **, 
p<0.01; ***/###, p<0.001 by one-way ANOVA followed by Tukey post-test. *, statistically 
significant compared with HD WT; #, statistically significant compared with M WT.  
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Fig S3. FIH-OTUB1 HD stability and formation kinetics. (A) Quantification of the 
experiment depicted in Fig 3A. (B) Illustration of the experimental procedures performed in 
Fig 3B and 3C. HEK293 cells were transiently co-transfected with FIH-V5 and FLAG-
OTUB1 WT, incubated in hypoxia (0.2% O2) for 24 h and instantaneously re-oxygenated in 
the presence or absence of 400 µM cycloheximide (CHX). (C) Quantification of the 
experiment depicted in Fig 3B. (D) Plasmid map of the bacterial bicistronic expression vector 
pST39-His-OTUB1-MBP-FIH. T7 Ø10, T7 promotor; T7 term, T7 terminator; ε, translational 
enhancer; SD, Shine-Dalgarno sequence. (E) Immunoblot analysis of co-inoculated bacterial 
cultures expressing either OTUB1 or FIH. Bacteria were transformed with either OTUB1 or 
FIH expression plasmids, cultivated separately and then mixed in a 1:1 ratio followed by 
induction of the indicated protein expression. HD, heterodimer; M, monomer; exp., exposure. 
Data are shown as mean + SEM from three independent experiments or are representative for 
(E) two independent experiments.  
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Fig S4. Quality control of purified FIH:FIH-OTUB1 HT and His-tagged OTUB1 and 
quantification of in vitro DUB activity assay. (A) His-OTUB1-MBP-FIH:FIH-MBP 
heterotrimer (His-MBP-HT) was purified from E.coli by sequential MBP- and Ni2+-affinity 
purification and analyzed by SDS-PAGE and colloidal Coomassie staining. (B) His-OTUB1 
was purified from E.coli by Ni2+-affinity purification and analyzed by SDS-PAGE and 
colloidal Coomassie staining. *, FIH-OTUB1 heterodimer (predicted MW: 117.82 kDa); **, 
monomeric MBP-FIH originating from the native protein complex (predicted MW: 83.78 
kDa); ***, monomeric His-OTUB1 (predicted MW: 34.04 kDa). (C) Quantification of each 
single Ub chain of the experiment depicted in Fig. 5C. Data are shown as mean + SEM from 
three independent experiments. *, p<0.05; **, p<0.01; ***, p<0.001 by two-way ANOVA 
followed by Tukey post-test.  
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Fig S5. FIH interactome under native and denaturing conditions. (A) Longer exposure of 
the FIH immunoblot shown in Fig 2A. (B) Protein abbreviations, full names and uniprot.org 
identifiers of proteins detected as FIH interactors under both lysis conditions. (C) Proteins 
shown in Fig 6C were analyzed and categorized for protein class using the Panther 
classification system (www.pantherdb.org). HD, heterodimer. Data were analyzed from (B, 
C) four biological replicates or are representative for (A) three independent experiments. 
